BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 13/02/2018

FDA Announces Guidance for Developing Drugs and Biologics for BCG-Resistant Nonmuscle Invasive Bladder Cancer

The FDA has finalized a guidance for industry to help develop treatments for patients with a rare form of bladder cancer that is resistant to current therapies, addressing an unmet medical need.

Source: Federal Register — Food and Drug AdministrationOpen original release →